Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Mayne Pharma Group Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 13 Dec 2023 | Inhibitor Therapeutics Enters into Licensing Agreement with Johns Hopkins University | Licensing Agreement |
Inhibitor Therapeutics Inc
|
Johns Hopkins University
|
| 04 Sep 2023 | Mayne Pharma to Acquire RHOFADE from Novan and EPI Health for USD8 Million | Asset Transaction |
Mayne Pharma Group Ltd
|
Novan Inc
EPI Health LLC
|
| 16 Jun 2023 | Mithra Pharmaceuticals to Sell 4.96% Stake in Mayne Pharma for USD11.13 Million | Acquisition | - |
Mayne Pharma Group Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer